Evidence map›Paper›PMID 35711685›Full record

ArticleLancet regional health. Americas2022

Drivers and scorecards to improve hypertension control in primary care practice: Recommendations from the HEARTS in the Americas Innovation Group.

Jeffrey W Brettler, Gloria P Giraldo Arcila, Teresa Aumala, Allana Best, Norm Rc Campbell, Shana Cyr, Angelo Gamarra, Marc G Jaffe, Mirna Jimenez De la Rosa, Javier Maldonado and 10 more

Abstract read
In one paragraph

Article in Lancet regional health. Americas, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Hypertension control applying the HEARTS in the Americas protocol in Trinidad: A cross-sectional study.Revista panamericana de salud publica = Pan American journal of public health · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Jeffrey W BrettlerSouthern California Permanente Medical Group, Los Angeles, CA, USA.
Gloria P Giraldo ArcilaDepartment of Non-Communicable Diseases and Mental Health. Pan American Health Organization (PAHO), Washington, DC, USA.
Teresa AumalaPrimary Health Care Center, Ministry of Health, Centro de Salud Conocoto, Quito, Ecuador.
Allana BestMinistry of Health, Park Street, Port of Spain, Trinidad and Tobago.
Norm Rc CampbellDepartment of Medicine, Physiology and Pharmacology and Community Health Sciences, Libin Cardiovascular Institute of Alberta, Calgary, AB, Canada.
Shana CyrMinistry of Health, Wellness & Elderly Affairs, Sir Stanislaus James Building, Waterfront, Castries, Saint Lucia.
Angelo GamarraDepartment of Non-Communicable Diseases and Mental Health. Pan American Health Organization (PAHO), Washington, DC, USA.
Marc G JaffeDepartment of Endocrinology, The Permanente Medical Group, Kaiser San Francisco Medical Center, San Francisco, CA, USA.
Mirna Jimenez De la RosaSchool of Public Health, Faculty of Health Sciences, Universidad Autónoma de Santo Domingo, Dominican Republic.
Javier MaldonadoPan American Health Organization, (PAHO), Bogotá, Colombia.
Carolina Neira OjedaDepartment of Noncommunicable Diseases, Ministry of Health, Santiago de Chile, Chile.
Modesta HaughtonPan American Health Organization (PAHO), Ancon, Panamá.
Taraleen MalcolmPan American Health Organization (PAHO), Port of Spain, Trinidad and Tobago.
Vivian PerezPan American Health Organization,(PAHO), Lima, Peru.
Gonzalo RodriguezPan American Health Organization, (PAHO), Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina.
Andres RosendeDepartment of Non-Communicable Diseases and Mental Health. Pan American Health Organization (PAHO), Washington, DC, USA.
Yamilé Valdés GonzálezNational Technical Advisory Committee on Hypertension, University Hospital "General Calixto García", Havana, Cuba.
Peter W WoodDepartment of Medicine, Division of General Internal Medicine, University of Alberta, Edmonton, AB, Canada.
Eric ZúñigaHealth Services Antofagasta, Servicio de Salud Antofagasta, Universidad de Antofagasta, Antofagasta, Chile.
Pedro OrdunezDepartment of Non-Communicable Diseases and Mental Health. Pan American Health Organization (PAHO), Washington, DC, USA.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Background: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the Americas, and hypertension is the most significant modifiable risk factor. However, hypertension control rates remain low, and CVD mortality is stagnant or rising after decades of continuing reduction. In 2016, the World Health Organization (WHO) launched the HEARTS technical package to improve hypertension control. The Pan American Health Organization (PAHO) designed the HEARTS in the Americas Initiative to improve CVD risk management, emphasizing hypertension control, to date implemented in 21 countries. Methods: To advance implementation, an interdisciplinary group of practitioners was engaged to select the key evidence-based drivers of hypertension control and to design a comprehensive scorecard to monitor their implementation at primary care health facilities (PHC). The group studied high-performing health systems that achieve high hypertension control through quality improvement programs focusing on specific process measures, with regular feedback to providers at health facilities. Findings: The final selected eight drivers were categorized into five main domains: (1) diagnosis (blood pressure measurement accuracy and CVD risk evaluation); (2) treatment (standardized treatment protocol and treatment intensification); (3) continuity of care and follow-up; (4) delivery system (team-based care, medication refill), and (5) system for performance evaluation. The drivers and recommendations were then translated into process measures, resulting in two interconnected scorecards integrated into the HEARTS in the Americas monitoring and evaluation system. Interpretation: Focus on these key hypertension drivers and resulting scorecards, will guide the quality improvement process to achieve population control goals at the participating health centers in HEARTS implementing countries. Funding: No funding to declare.

Indexed as

Cardiovascular diseaseHypertensionLatin America and the CaribbeanNoncommunicable diseasesQuality improvement

Identifiers

PMID35711685
PMCPMC9121401

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.